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Abstract
We have previously reported that the absence of sphingosine kinase 1 (SK1) affects both
dengue virus (DENV) infection and innate immune responses in vitro. Here we aimed to
define SK1-dependancy of DENV-induced disease and the associated innate responses in
vivo. The lack of a reliable mouse model with a fully competent interferon response for
DENV infection is a challenge, and here we use an experimental model of DENV infection in
the brain of immunocompetent mice. Intracranial injection of DENV-2 into C57BL/6 mice
induced body weight loss and neurological symptoms which was associated with a high
level of DENV RNA in the brain. Body weight loss and DENV RNA level tended to be greater
in SK1-/- compared with wildtype (WT) mice. Brain infection with DENV-2 is associated with
the induction of interferon-β (IFN-β) and IFN-stimulated gene (ISG) expression including
viperin, Ifi27l2a, IRF7, and CXCL10 without any significant differences between WT
and SK1-/- mice. The SK2 and sphingosine-1-phosphate (S1P) levels in the brain were
unchanged by DENV infection or the lack of SK1. Histological analysis demonstrated the
presence of a cellular infiltrate in DENV-infected brain with a significant increase in mRNA
for CD8 but not CD4 suggesting this infiltrate is likely CD8+ but not CD4+ T-lymphocytes.
This increase in T-cell infiltration was not affected by the lack of SK1. Overall, DENV-infec-
tion in the brain induces IFN and T-cell responses but does not influence the SK/S1P axis.
In contrast to our observations in vitro, SK1 has no major influence on these responses fol-
lowing DENV-infection in the mouse brain.
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Introduction
Sphingolipids, which are an integral part of membranes in all eukaryotic cells, have been
involved in a variety of cell signalling functions [1]. One of these signalling sphingolipids is
sphingosine-1-phosphate (S1P) which has well-known critical roles in cell growth and devel-
opment [2] and T-lymphocyte recruitment [3]. This latter property has drawn considerable
recent attention and has led to the clinical use of S1P analogues in the treatment of diseases
such as multiple sclerosis [4]. S1P is a normal metabolite produced following the phosphory-
lation of sphingosine by the sphingosine kinases (SKs) which can play an important role
in cell signalling and inflammation [5]. For example, a recent study by Harikumar et al.,
showed that SK1 was required for interferon regulatory factor (IRF)-1- mediated induction
of CXCL10 and CCL5 chemokines following interleukin 1 (IL-1) stimulation [6]. There are
two forms of SK, designated SK1 and SK2 [7]. Both isozymes show a high degree of sequence
similarity although they vary in size, catalytic properties, tissue distribution, and subcellular
localisation [8], and have been proposed to have complementing but also distinct physiologi-
cal roles [1, 9].
A role for SK1 during viral infections is emerging, as we have recently reviewed [10]. Sev-
eral viruses have been shown to modulate the activity or level of SK1 for efficient viral infec-
tion. For instance, bovine viral diarrhoea virus (BVDV) reduced the catalytic activity of SK1 to
promote viral replication [11]. In contrast, an increase of SK1 expression and activity during
human cytomegalovirus (HCMV) [12], influenza A virus [13], and measles virus (MV) [14]
infections enhanced viral replication. Moreover, SK1 can promote viral infections through dif-
ferent biological mechanisms. SK1 has been shown to prolong survival of virus-infected cells
[12], and viral protein synthesis [14]. We have previously shown that SK1 activity is altered
during dengue virus (DENV) infection [15, 16], and that a reduction in SK1 affects the ability
of DENV to induce interferon-stimulated genes (ISGs) in vitro [17]. Here, we investigated the
effect of SK1 on DENV replication and the induction of ISGs using an in vivo model compris-
ing intracranial (ic) injection of DENV.
DENV is a globally important human pathogen that can cause a wide spectrum of clinical
presentations from a febrile illness to a life threatening infection with bleeding complica-
tions [18]. The disease severity and pathogenicity is thought to be immune-mediated in
which immune responses to DENV exacerbate damage to the host [19–21]. Unlike DENV-
infection in humans, DENV does not replicate well or cause symptoms reflective of human
disease in immunocompetent wild type (WT) mice [22], but can cause a similar pathology
in mice deficient in the interferon (IFN) response, such as in the AG129 IFN receptor
knockout mouse model [23]. Analysis of neurovirulence—the induction of symptoms of
brain infection including reduction in hind limb function has been a widely used historical
method to indicate the presence of virus following ic inoculation. Ic injection of DENV into
WT mice, although not reflective of a natural mode of DENV-infection, is associated with
DENV replication and neurological symptoms [24, 25] but additionally, may reflect some
aspects of DENV-associated neurological disease in humans [26]. Although DENV does not
antagonise IFN responses in mice as it does in humans [27], in our study we utilised the
DENV ic mouse infection model as a means to assess the role of SK1 in DENV infection and
induction of ISGs in vivo in an immunocompetent animal. We compared virus replication
and immune responses following ic injection of DENV into WT and SK1-/- mice. Our data
define novel ISG and T-cell responses, and a lack of change in the SK/S1P axis in the brain
following DENV infection and demonstrate that SK1 is not a key regulator of these processes
in the brain.
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Materials and Methods
Ethics statement
All animal procedures were performed in accordance with Flinders University Animal Welfare
committee approval number 870/14 and Institutional Biosafety Committee approval NLRD
2011–10.
Mice
Three to four weeks of age WT C57BL/6 (n = 24) and homozygous knockout for the Sphk1
gene encoding SK1 (SK1-/-) (n = 17) [28] mice were used in this study. All mice were kept in a
pathogen-free environment on a 12 hours cycle of light and darkness with ad libitum access to
food and water.
Virus production
Mice were infected using MON601, a full-length cDNA clone of DENV-2 New Guinea C
strain [29]. The virus stock was produced from in vitro transcribed RNA that was transfected
into baby hamster kidney clone 21 (BHK-21) cells and amplified in Aedes albopictus C6/36
cells. Cell culture supernatants containing virus was harvested, clarified, filtered, and stored
at– 80˚C. The titre of infectious virus was determined by plaque assay using African green
monkey kidney (Vero) cells and quantitated as plaque forming unit per ml (pfu/ml).
DENV-2 challenge and follow-up
WT and SK1-/- mice were anaesthetised by isoflurane inhalation, and infected by ic injection
with 800 pfu of DENV-2 MON601 diluted in phosphate-buffered saline (PBS) in a volume of
10 μl. Mock control mice were injected ic with PBS. Animals were visually monitored twice
daily for signs of DENV-induced neurological disease including slow movement, hunched
posture, or reduction in hind limb function. In addition, animals were monitored for body
weight. Any sign of neurological disease or loss of more than 10% of body weight represented
a termination point and animals were sacrificed immediately by isoflurane anaesthetic inhala-
tion and humane decapitation. Brain tissues were harvested at sacrifice and divided into two
parts. The ipsilateral section was resuspended in TRIzol reagent (Ambion Life Technologies)
for RNA extraction and real-time quantitative PCR (qRT-PCR) analysis and the contralateral
section was snap frozen in liquid nitrogen for SK activity assay and S1P quantification or fixed
for histological analysis.
Real-time quantitative RT-PCR
Total RNA was extracted from brain tissues using TRIzol (Ambion Life Technologies), accord-
ing to the manufacturer’s instructions. The extracted RNA was DNase I treated (Zymo
Research) and quantitated by spectrophotometry (NanoDrop elite, Thermo Scientific). Total
RNA (0.5 μg) was reverse transcribed using M-MuLV reverse transcriptase (NEB) and random
hexamers (NEB) in a 20 μl final volume, and subjected to a real-time qRT-PCR. qRT-PCR was
carried out using 2 μl of cDNA template in a 10 μl reaction using iTaq SYBER green (BioRad)
with 20 μM of each forward and reverse primer. All PCR primers were synthesised by Gene-
Works with sequences as listed in Table 1. Real-time qRT-PCR was performed using Rotor-
Gene 3000 real-time PCR system (Corbett research, Australia) under the following conditions:
one cycle of 95˚C for 5 minutes; 45 cycles of 95˚C for 15 seconds, 59˚C for 30 seconds, and
72˚C for 30 seconds; and one cycle of 72˚C for 60 seconds followed by melt curve analysis.
Quantitative DENV copy number was calculated from a standard curve generated from
Dengue Virus Induces ISGs in the Mouse Brain
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known concentration of MON601 DNA quantitated by spectrophotometry. DNA copy num-
bers from 15 pg/μl to 0.015 pg/μl were analysed in concurrent real-time PCR to generate a
standard curve from which unknown DENV RNA copy numbers were calculated. Relative
RT-PCR quantitation was determined by the ΔCt method [30] for all other genes. All PCR
reactions were normalised against the reference housekeeping gene glyceraldehyde-3-phos-
phate dehydrogenase (GAPDH).
Measurement of sphingosine kinase activity
Frozen brain tissues were homogenised and sonicated in a buffer consisting of 50 mM Tris/
HCl (pH 7.4) containing 150 mM NaCl, 2 mM Na3VO4, 10 mM NaF, 10% (w/v) glycerol, 10
mM β-glycerophosphate, 0.05% (w/v) Triton X-100, 1 mM EDTA and protease inhibitors
(Roche, Complete mini). SK1 and SK2 activities were selectively measured by 32P transfer
from [γ32P] ATP to D-erythro-sphingosine under conditions of Triton X-100 for SK1 activity
and 1 M KCl for SK2 activity, as previously described [31]. The SK activities were normalised
against total protein content, as determined by Bio-Rad protein assay.
S1P quantitation
S1P levels were measured as previously described [32] with some modifications. Briefly, 20 μl
of brain homogenate was suspended in 200 μl methanol with 0.25% conc. HCl. Alkaline
extraction of the lipids was performed by addition of 400 μl chloroform, 30 μl of 10 M NaOH,
580 μl of 2 M KCl and 200 μl methanol with 200 pmol C17-S1P and centrifuged (5 min,
16000xg). The upper aqueous/methanol phase was collected and acid extraction was per-
formed with 40 μl conc. HCl and 300 μl chloroform. The upper phase was aspirated and 200 μl
Table 1. Primer sequences used in this study for qRT-PCR.
Name Primers Sequence Accession No.
DENV-2 capsid region Forward GCAGATCTCTGATGAATAACCAAC D00346.1
Reverse TTGTCAGCTGTTGTACAGTCG
GAPDH Forward GACGGCCGCATCTTCTTGTGC NM_008084.3
Reverse TGCCACTGCAAATGGCAGCC
SK1 Forward TGTCACCCATGAACCTGCTGTCCCTGCACA NM_001172475.1
Reverse GCCCTTCTGCACCAGTGTA
SK2 Forward TCTGGAGACGGGCTGCTTTA NM_001172561.1
Reverse GCACCCAGTGTGAATCGAGC
IFN-β Forward AGAAAGGACGAACATTCGGAAA NM_010510.1
Reverse CCGTCATCTCCATAGGGATCTT
Viperin Forward ACTCTGTCATTAATCGCTTCAACGT NM_021384.4
Reverse TCAATTAGGAGGCACTGGAAAAC
Ifi27l2a Forward CTGTTTGGCTCTGCCATAGGAG NM_029803.3
Reverse CCTAGGATGGCATTTGTTGATGTGG
IRF7 Forward CACCCCCATCTTCGACTTCA NM_001252601.1
Reverse CCAAAACCCAGGTAGATGGTGTA
CXCL10 Forward GCCGTCATTTTCTGCCTCAT NM_021274.2
Reverse GGCCCGTCATCGATATGG
CD4 Forward CCCAGGTCTCGCTTCAGTTTG NM_013488.2
Reverse AGGTAGGTCCCATCACCTCACAG
CD8-β Forward GCTGGTAGTCTGCATCCTGCTTC NM_009858.2
Reverse TTGCTAGCAGGCTATCAGTGTTGTG
doi:10.1371/journal.pone.0169814.t001
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of lower choloroform phase was collected and chloroform was evaporated using a speed vac-
uum system. The dried lipids were resuspended in 275 μl methanol/70 mM K2HPO4 (9:1) with
1 mM EDTA by sonication in a bath sonicator for 30 sec. A derivatization mixture of 10 mg o-
phthalaldehyde, 200 μl ethanol, 10 μl β-mercaptoethanol and 10 ml of a 3% boric acid solution
(adjusted to pH 10.5 with KOH) was prepared and 25 μl of this was added to the lipid samples
and incubated for 15 min at room temperature followed by centrifugation. S1P levels were
then determined by HPLC analysis with an EVO C18 column (Phenomenex, Lane Cove,
NSW, Australia) as previously described [32].
Histological analysis
Mouse brains were harvested and fixed in 10% (v/v) buffered formalin. Brain tissues were
embedded and block mounted in paraffin. Sections were cut into 5μm thickness, stained with
haematoxylin and eosin (H&E) and examined under brightfield microscopy (BX50,
Olympus).
Statistical analysis
Statistical analyses were carried out using GraphPad Prism software version 6.07. A statistically
significant difference between samples was assessed using Students unpaired t-test with
Welch’s correction. Kaplan-Meier survival curves were analysed by log rank test (Mantel-
Cox). To examine the body weight loss and appearance of clinical signs of disease Fisher’s
exact test was used.
Results
DENV-2 -infection induces neurological symptoms and weight loss in WT and SK1-/-
mice. To define the susceptibility of WT and SK1-/- mice to DENV-2 ic infection, we com-
pared the growth rates and survival of mock and DENV-infected WT and SK1-/- mice. Ani-
mals were challenged by ic injection with 800 pfu/mouse DENV-2, and body weight and
neurological symptoms (slow movement, hunched posture, and reduction in hind limb move-
ment) recorded daily. Mock-infected mice did not demonstrate any loss in body weight or
neurological symptoms (Fig 1A–1D). Although there was a tendency towards a greater and
earlier body weight loss in DENV-infected SK1-/- mice compared with DENV-infected WT
mice, there was no significant difference in terms of the overall number of mice that lost body
weight, the time of onset of body weight loss, nor the percentage of mice that lost more than
7% of body weight (Table 2). When average body weight gain as a percentage of the initial
body weight was analysed, results showed that both DENV-infected WT mice and SK1-/- mice
started to lose body weight at 6 days post infection (dpi) in comparison to mock-infected mice
(Fig 1A and 1C). As expected, analysis of survival demonstrated a significantly higher mortal-
ity in DENV-infected compared to mock-infected mice (Fig 1B and 1D). Comparison of body
weight loss and survival of DENV-infected WT and SK1-/- mice support the trends in Table 2
and demonstrate that DENV-infected SK1-/- mice show a significantly greater weight loss at 7
dpi than WT mice (Fig 1E). At this time point, 7 out of 17 WT mice (~41%) and 7 out of 13
SK1-/- mice (~54%) were sacrificed due to either excessive body weight loss and/or appearance
of signs of DENV-induced neurovirulence. This is reflected by an apparent higher survival
rate of WT compared to SK1-/- mice at 7 and 8 dpi, although this was not statistically signifi-
cant (Fig 1F). These results suggest that C57BL/6 mice deficient in SK1 tend to be more sus-
ceptible to body weight loss following DENV-2 infection than their counterpart WT mice but
the overall disease profile is comparable.
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Fig 1. Susceptibility of WT and SK1-/- mice to DENV-2 infection. 3–4 week old C57BL/6 WT (n = 17) and SK1-/- (n = 13)
mice were ic injected with 800 pfu DENV-2 MON601. Mock WT (n = 7) and SK1-/- (n = 4) control mice were ic injected with
vehicle only. Body weight and neurological symptoms were recorded. Body weight is expressed as a percentage of initial
body weight. Survival reflects mice that do not show neurological symptoms or >10% of body weight loss. A and B.
Comparison of body weight and survival curves of mock with DENV-infected WT mice; C and D. Comparison of body
Dengue Virus Induces ISGs in the Mouse Brain
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DENV-2 RNA levels are not significantly different between WT and SK1-/- mice but cor-
relate with DENV-induced disease. DENV replication in the brain following ic injection
was validated by analysis of the time course of DENV RNA changes in WT mice. qRT-PCR
analysis demonstrated increasing DENV RNA level with time with 3 dpi representing an early
time point where DENV RNA levels were increasing (Fig 2A). Eight WT or SK1-/- mice were
injected ic with DENV-2 and brain tissues harvested at 3 dpi. DENV RNA levels at 3 dpi
tended to be higher in SK1-/- compared with WT mice (p = 0.083), but were not significantly
different (Fig 2B). RNA levels were also quantitated in WT and SK1-/- mice at the termination
of experiments. DENV RNA level was significantly higher at day 7–8, than at 9–14 dpi in both
WT and SK1-/- mice (Fig 2C). The sacrifice of mice at 7–8 dpi was due to symptomatic presen-
tation and ethical termination, but those sacrificed at 9–14 dpi showed body weight loss but
lacked neurological symptoms and represented an elective time for termination of the experi-
ment. Based on the disease presentation and comparable level of DENV RNA at 7 and 8 dpi,
we have considered this combined time point as ‘end-stage disease’. We have indicated the
9–14 dpi animals in Figs 4–7 as half-filled symbols but excluded these animals from our statis-
tical analysis since they did not show DENV-induced disease. It should be noted, however that
the inclusion of the 9–14 dpi mice in the data set did not influence the statistical outcomes. At
end-stage disease (7–8 dpi), DENV RNA levels again tended to be higher in SK1-/- mice brains
in comparison to WT mice (Fig 2C) but were not significantly different (p = 0.116). These data
suggest that DENV-2 can replicate and cause body weight loss and neurological symptoms
when introduced directly into the mouse brain, with a moderate but not statistically significant
increase in DENV RNA in SK1-/- compared to WT mice.
DENV-2 infection induces IFN-β and interferon-stimulated genes (ISGs) but this is not
different in WT and SK1-/- mice. Type I interferon, such as IFN-β, is an important part of
the early immune response to DENV infection and to define this response following DENV-2
infection in the brain we analysed mRNA levels for IFN-β and the ISG’s viperin, Ifi27l2a, IRF7
weight and survival curve of mock with DENV-infected SK1-/- mice; E and F. Comparison of body weight percentage and
survival curves of DENV-infected WT and SK1-/- mice. Data are expressed as mean ± SEM. Statistical analysis of survival
curves were determined by long-rank test. * = p < 0.05, ** = p < 0.005.
doi:10.1371/journal.pone.0169814.g001
Table 2. Summary of body weight loss and signs of DENV-induced neurovirulence in WT and SK1-/- mice and analysed by Fisher’s exact test.
Criteria Mice strains P
WT SK1-/-
Number % Number %
Body weight loss
Weight loss 15 88.24 12 92.31 0.999
No weight loss 2 11.76 1 7.69
% Body weight loss
< 7% 8 53.33 2 16.67 0.107
> 7% 7 46.67 10 83.33
Days pi onset loss
< 7 dpi 3 20.00 5 41.67 0.398
 7 dpi 12 80.00 7 58.33
Appearance of neurovirulence
Neurovirulence 10 58.82 9 69.23 0.708
No neurovirulence 7 41.18 4 30.77
doi:10.1371/journal.pone.0169814.t002
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Fig 2. DENV-2 RNA levels increase WT and SK1-/- mice following ic DENV infection. WT and SK1-/-
mice were ic infected with DENV, as in Fig 1. RNA was isolated from infected mice brain tissues and analysed
by real time qRT-PCR for DENV. A. Total DENV-2 RNA increases with time in WT mice, n = 3 at each time
point; B. RNA was isolated from infected WT and SK1-/- mice brain tissues at 3 dpi, n = 8 for each strain; C.
RNA was isolated from infected mice brain tissues at the time of humane sacrifice, representing 7 (n = 7), 8
Dengue Virus Induces ISGs in the Mouse Brain
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and CXCL10 in WT mice by qRT-PCR. Results show increased IFN-β mRNA, late in the
course of infection at 6 dpi (Fig 3A). In comparison to this late induction of IFN-β, all the ISGs
analysed were rapidly and significantly induced, as early as 1 dpi, for viperin and IRF7 or 3
dpi, for Ifi27l2a and CXCL10 (Fig 3B).
Comparison of responses in WT and SK1-/- mice at 3 dpi, showed that IFN-β and ISGs
(viperin, Ifi27l2a, IRF7 and CXCL10) mRNA levels were induced following DENV-infection
but did not differ between WT and SK1-/- mice (Fig 4A). At end stage disease, IFN-β mRNA
levels tended to be increased (p = 0.224 WT; 0.086 SK1-/-), while the ISGs viperin, Ifi27l2a,
IRF7 and CXCL10 were all significantly and highly induced by DENV-infection (Fig 4B). As
seen at 3 dpi (Fig 4A), IFN-β and ISG mRNA levels were not significantly different between
DENV-infected WT and SK1-/- mice at end stage disease (Fig 4B). These data suggest that
ISGs are induced early during DENV infection in the mouse brain, prior to the detectable
induction of IFN-β, with the induction of ISGs persisting until end stage disease. The lack of
SK1 however, has no effect on this response.
DENV-2 infection in the brain does not alter the SK/S1P axis. To validate the lack of
SK1 in SK1-/- mice and assess the impact of this and DENV-infection on the SK/S1P axis in
the brain, we quantitated SK1 and SK2 mRNA, performed isoform-specific SK activity assays
and determined S1P levels in the brain at end stage disease. qRT-PCR for SK1 mRNA and in
vitro assays for SK1 activity in the brain verified the lack of SK1 in the mice (Fig 5A). Addition-
ally, neither SK1 mRNA nor activity were altered in DENV-infected WT mice (Fig 5A). The
lack of SK1 could be compensated for by an increase in SK2 levels. Results, however demon-
strated no change in SK2 mRNA nor SK2 activity in SK1-/- mice brains (Fig 5B). Again, neither
SK2 mRNA or SK2 activity was altered in DENV-infected WT or SK1-/- mice (Fig 5B). Fur-
ther, S1P levels were quantitated in brain lysates. Notably, S1P levels were not different
between WT and SK1-/- mice, nor did they change following DENV-infection of either mouse
strain (Fig 5C).
DENV-2 infection induces CD8+ but not CD4+ T-cell infiltration in the brain.
CXCL10 which we have demonstrated to be induced (Figs 3 and 4), and S1P which is
unchanged following DENV-infection, can both influence T-cell migration. Thus, we exam-
ined cell infiltration by histological H&E staining and the presence of mRNA for the T-lym-
phocyte markers, CD4 and CD8 by qRT-PCR in WT mouse brain tissue throughout the
course of DENV ic infection. H&E staining of fixed brain tissue demonstrated the presence of
a cellular infiltrate at 6 dpi in DENV compared to mock-infected mouse brain (Fig 6A). Results
show no change in the level of CD4, but a marked and significant increase in CD8 by day 6 pi
(Fig 6B), suggesting CD8+ T-cell infiltration following DENV-infection in the WT mouse
brain.
The levels of CD4 and CD8 mRNA were compared by qRT-PCR in WT and SK1-/- mice at
3 dpi and end stage disease (Fig 7). Results again demonstrate a lack of increase in CD4 mRNA
levels following DENV-infection of WT or SK1-/- mice at either time point pi and no signifi-
cant difference between DENV-infected WT and SK1-/- mice (Fig 7A). The levels of CD8
mRNA, however were significantly higher in DENV-infected WT and SK1-/- mice compared
to their mock-infected controls at end stage disease (Fig 7B), but once again there was no sig-
nificant difference in CD8 mRNA between DENV-infected WT and SK1-/- mice. These data
suggest that CD8+ but not CD4+ T-lymphocytes infiltrate the brain of DENV-infected mice
(n = 5), 9 (n = 4) or 14 (n = 1) dpi for WT and 7 (n = 7), 8 (n = 3), 9 (n = 2) or 14 (n = 1) dpi for SK1-/- mice. Each
symbol represents an individual mouse sample. Data represent average PCR values from individual mice.
Statistical significance was assessed by unpaired Student t-test.
doi:10.1371/journal.pone.0169814.g002
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Fig 3. The time course of induction of IFN-β and ISGs in WT mice following ic infection with DENV-2. WT
mice (n = 3 at each time point) were ic infected with DENV, as in Fig 1. At the time point indicated RNA was
isolated from infected mice brain tissues and analysed by real time qRT-PCR for A. IFN-β; B. ISGs viperin,
Ifi27l2a, IRF7 and CXCL10. Data represent average PCR values from individual mice and normalized against
GAPDH by ΔCt method. Statistical significance was assessed by unpaired student t-test * = p < 0.05, ** =
p < 0.005, *** = p < 0.0005.
doi:10.1371/journal.pone.0169814.g003
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Fig 4. Induction of IFN-β and ISGs in WT and SK1-/- mice following ic infection with DENV-2. WT and
SK1-/- mice were ic infected with DENV, as in Fig 1. RNA was isolated from infected mice brain tissues and
analysed by real time qRT-PCR A. at 3 dpi for IFN-β, viperin, Ifi27l2a, and CXCL10. n = 8 WT and SK1-/-
DENV-infected, n = 2 WT mock and n = 3 SK1-/- mock-infected mice; B. at end stage disease for IFN-β,
viperin, Ifi27l2a, and CXCL10. n = 12 WT and n = 10 SK1-/- DENV-infected, n = 7 WT mock and n = 4 SK1-/-
Dengue Virus Induces ISGs in the Mouse Brain
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but there is no major role of SK1 in driving CD8+ T-cell migration into the brain during
DENV-infection.
Discussion
A growing number of studies have reported SK1 as a factor that contributes to the modulation
of several viral infections in vitro [10]. Our own studies have suggested changes in SK1 in
response to DENV-2 infection [15, 33] and a role for SK1 early in infection in promoting
DENV-induction of ISGs in vitro [17]. In the study here we have investigated the role of SK1
during DENV-2 infection in vivo using immunocompetent C57BL/6 mice and direct ic DENV
infection.
Following DENV-2 infection, as expected, WT and SK1-/- mice exhibited body weight loss
and signs of neurovirulence compared to mock-infected mice. This reflects the pathogenicity
and virulence of the DENV-2 MON 601 strain in mouse brain, as has been previously reported
[29, 34]. Similar to other studies of DENV ic infection, not all mice develop neurological symp-
toms [29, 34]. We have further shown here that symptomatic DENV-infection with body
weight loss and neurological signs is positively associated with the level of DENV RNA in the
brain with a lower level of DENV RNA in the brains of asymptomatic mice at 9–14 dpi. The
data from these mice has been represented graphically but we have excluded these from our
statistical analysis. Interestingly, these asymptomatic mice strikingly group together with lower
induction of viperin compared to symptomatic mice (Fig 4B) but are interspersed with the
symptomatic mice in terms of responses such as CD8+ mRNA levels (Fig 7B). This suggests an
association of viperin with symptomatic DENV-infection in the brain, and this remains to be
investigated further.
Mice that are deficient in SK1 showed moderately greater and earlier body weight loss and
tended to have higher levels of DENV RNA following DENV-2 infection than their counter-
part WT mice. Since SK1 is a pro-survival factor [35], it is possible that without SK1 mice are
more prone to weight loss and growth deficiencies. Additionally, the trend towards an increase
in DENV RNA in SK1-/- mice, although not statistically significant (p = 0.116), is consistent
with our recent data showing enhancement of DENV-2 infection in SK1-/- primary mouse
embryonic fibroblast (MEF), that we demonstrated is associated with a reduced ability of
DENV to induce ISGs in the absence of SK1 [17]. Thus, we assessed the SK1-dependency of
the induction of ISGs in this DENV-brain infection model. We chose to analyse the mRNA
level of selected important type I IFN driven ISGs: viperin [36], IRF7 [37], and CXCL10 [38]
that have been described previously as antiviral factors against DENV and we have previously
shown to be induced in a SK1-dependent manner in response to DENV infection in vitro [17].
Ifi27l2a was also assessed as an ISG, previously reported to be induced in the brain in response
to West Nile Virus (WNV) infection [39], and for which the response to DENV-infection has
not been previously defined. At 6 dpi and end stage disease the level of IFN-β mRNA tended
to be increased. In contrast there was a more rapid (1–3 dpi) and significant induction of ISGs
viperin, Ifi27l2a, IRF7 and CXCL10 that persisted until end stage disease. IFIT1 and OAS1,
which are similarly anti-viral against DENV [40, 41] were also induced rapidly but were not
analysed in our complete experimental set (data not shown). This is the first report of
mock-infected mice. Data points representing non-symptomatic animals (9–14 dpi) are indicated by the half-
filled symbols. Statistical analysis has been performed on symptomatic DENV-infected mice only (7–8 dpi),
excluding n = 5 WT and n = 3 SK1-/- at 9/14 dpi. Data represent average PCR values from individual mice and
normalized against GAPDH by ΔCt method. Statistical significance was assessed by unpaired student t-test.
* = p < 0.05, ** = p < 0.005, *** = p < 0.0005, **** = p < 0.00005.
doi:10.1371/journal.pone.0169814.g004
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Fig 5. Definition of the SK/S1P axis in WT and SK1-/- mice following ic infection with DENV-2. WT and
SK1-/- mice were ic infected with DENV, as in Fig 1 and at end stage disease, brain tissue was harvested and
snap frozen or stored in TRIzol. RNA was extracted from TRIzol and lysates prepared in EB buffer from snap
frozen tissue. A. SK1 mRNA was determined by qRT-PCR (left panel) and isoenzyme specific SK1 activity assay
(right panel); B. SK2 mRNA was determined by qRT-PCR (left panel) and isoenzyme specific SK2 activity assay
Dengue Virus Induces ISGs in the Mouse Brain
PLOS ONE | DOI:10.1371/journal.pone.0169814 January 17, 2017 13 / 21
induction of these ISGs in the brain following DENV-infection and the first report of DENV-
induction of Ifi27l2a. The discordance between the induction of IFN-β and these ISGs con-
trasts to studies that show IFN-β to be a major driver of neuronal ISGs response during WNV
infection in the brain [42, 43] and ISGs following DENV-infection in some cells [16, 44]. This
(right panel); C. S1P was quantitated in brain lysates by HPLC. n = 11 WT and n = 10 SK1-/- DENV-infected, n = 7
WT mock and n = 4 SK1-/- mock-infected mice. PCR data represent average PCR values from individual mice
and normalized against GAPDH by ΔCt method. SK activity data and S1P quantitation are expressed relative to
total protein quantitation. Statistical significance was assessed by unpaired student t-test. ** = p < 0.05, **** =
p < 0.00005. ND, not detected. Data points representing non-symptomatic animals (9–14 dpi) are indicated by
the half-filled symbols. Statistical analysis has been performed on symptomatic DENV-infected mice only,
excluding n = 5 WT and n = 3 SK1-/- at 9/14 dpi.
doi:10.1371/journal.pone.0169814.g005
Fig 6. T-cell infiltration in the brain of WT mice following ic infection with DENV-2. WT mice were ic infected with DENV, as in Fig 1 and brain
tissue was harvested. A. at 3 and 6 dpi, tissue was fixed and processed for H&E staining. Images are representative of n = 3 mice. Arrows indicate
sites of cellular infiltrate; B. at the indicated time point RNA was extracted and CD4 and CD8 mRNA determined by qRT-PCR with n = 3 mice at each
time point. Data represent average PCR values from individual mice and normalized against GAPDH by ΔCt method. Statistical significance was
assessed by unpaired student t-test. * = p < 0.05.
doi:10.1371/journal.pone.0169814.g006
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suggests that IFN-β may not be the major driver of induction of these ISGs following DENV
infection in the brain. Potentially, other factors such as IFN-γ or λ may be more important in
this tissue [45–47]. Studies have shown the activation of microglial cells, an increase in neuro-
logical disease severity when these cells are depleted and a role for microglia in production of
cytokines and chemokines such as RANTES, IFN-γ, IL-6, MCP-1 and MCP5 following
Fig 7. T-cell infiltration in the brain of WT and SK1-/- mice following ic infection with DENV-2. WT and SK1-/- mice were ic infected with DENV,
as in Fig 1 and brain tissue harvested at 3 dpi and end stage disease. RNA was isolated from infected mice brain tissues and analysed by real time
qRT-PCR for A. CD4 mRNA; B. CD8 mRNA. At 3 dpi n = 8 WT and SK1-/- DENV-infected, n = 2 WT mock and n = 3 SK1-/- mock-infected mice. At end
stage disease (7–8 dpi) n = 12 WT and n = 10 SK1-/- DENV-infected, n = 7 WT mock and n = 4 SK1-/- mock-infected mice. Data points representing
non-symptomatic animals (9–14 dpi) are indicated by the half-filled symbols. Statistical analysis has been performed on symptomatic DENV-infected
mice only, excluding n = 5 WT and n = 3 SK1-/- at 9/14 dpi. Data represent average PCR values from individual mice and normalized against GAPDH
by ΔCt method. Statistical significance was assessed by unpaired student t-test. * = p < 0.05, ** = p < 0.005, *** = p < 0.0005.
doi:10.1371/journal.pone.0169814.g007
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DENV-infection in the brain [48]. Similarly, in our model of DENV-ic infection, these resi-
dent microglial cells may be the source of the induction of ISGs we have observed here.
The induction of ISGs is evident prior to the presence of symptomatic infection but was not
significantly different between WT and SK1-/- mice. This contrasts to our prior data from in
vitro studies where embryonic fibroblasts from SK1-/- mice or cells treated with an SK1 inhibi-
tor (SK1-I) show reduced DENV-induction of ISGs such as viperin, IFIT1 and CXCL10 [17].
Similarly, genetic deletion or chemical inhibition of SK1 reduced the IL-1 induced expression
of CXCL10 [6]. This suggests that in contrast to MEF and peripheral responses, the deficiency
of SK1 does not compromise the induction of ISGs in the model herein of DENV-infection of
the brain. Further, that lack of a major effect of the lack of SK1 on DENV-disease suggests that
similarly SK1-dependent inflammatory pathways are not involved in regulating DENV repli-
cation and pathogenicity in the brain. This contrasts to LPS [49] or ischemia-induced neuroin-
flammation [50] where SK1 has been shown to be present in microglia and to promote the
induction of factors such as TNF-α, IL-1 and nitric oxide [49] but intriguingly a lack of SK1
exacerbates LPS induced neuroinflammation [51]. Our observed lack of influence of SK1 on
DENV in the brain may be due to pathogen or stimulus specific roles for SK1 in brain inflam-
mation or tissue specific roles for SK1, where in the brain SK2 is known to be the dominant SK
isoform [52]. The brain is an immune privileged site and previous studies have also reported
differences in the expression of ISGs between the brain and other tissues. For example, mRNA
levels for genes such as OAS, MDA5, and STAT1 as well as ISGs IFIT1, IFIT2, and ISG15 are
greater in the liver than the brain of mice [53, 54]. Studies also showed expression of ISGs vary
between the different cell types within the brain itself. For example, the basal and inducible lev-
els of OAS were lower in neurons than microglia in response to MHV infection [53] and
higher levels of both basal and induced ISGs (e.g. IFIT1 and IRF7) are observed in microglia
than oligodendrocytes [53, 55]. Additionally, mouse cortical neurons fail to express basal levels
of ISG54 and ISG56 [56] while distinct neuronal subsets in the brain differentially express
Ifi27, IRF1 and viperin that make these cells more susceptible to WNV infection [43]. Thus,
although we saw no overall effect of a lack of SK1 in a whole brain extract, and in situ analysis
of SK1 and ISGs in different cells of the brain may be informative.
The SK/S1P axis is a finely regulated system [57]. Our findings demonstrated that the lack
of SK1 in the mouse brain was not compensated for by changes in SK2 mRNA or activity, con-
sistent with prior studies in the periphery [28, 58]. Further, SK1-/- mice do not have altered lev-
els of S1P in the brain. Additionally, DENV-infection did not affect SK1 or SK2 mRNA or
activity in the brain. This contrasts to the early increase in SK1 activity that we have docu-
mented in DENV-infected EC [16] and inhibition late in infection in a number of cell types in
vitro [15], which again may reflect tissue-specific responses of SK1 to infection. Further, SK2
mRNA or activity or S1P levels in the brain were not different following DENV-infection of
WT and SK1-/- mice.
Following viral infection, one would expect to see an immune cell infiltrate to the site of
infection. We demonstrated a marked cell infiltrate in DENV-infected mouse brain by H&E
staining and further characterised the nature of this cellular infiltrate as CD8+ but not CD4+
T-cells by RT-PCR analysis, although we did not analyse the presence of monocytes, a cell type
also known to infiltrate the brain in WNV infection [59, 60]. A prior study has shown both
CD4+ and CD8+ T cells infiltration into the brain following DENV-3 challenge in C57BL/6
mice [25], or DENV-2 challenge in BALB/c mice [34]. Further, Hsieh et al. showed predomi-
nant CD8+ compared to CD4+ T cell infiltration in DENV-infected mouse brain [38]. Simi-
larly, the infiltration of T cells has been demonstrated in mouse brains during infection with
other flaviviruses. Increased CD8+ but not CD4+ mRNA levels were detected in Japanese
encephalitis virus (JEV)-infected mouse brains [61], and similarly CD8+ T-cells infiltrate
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WNV-infected mouse brains [62] and following ic challenge with the Alphavirus, Semliki For-
est virus (SFV) [63]. In contrast, both CD4+ and CD8+ T cells have been reported in mice
challenged with a WNV [60, 64] and Yellow fever (YF)-17D virus [65]. Thus, there is an overall
consensus from a number of flavivirus and other virus infections in the brain that CD8+ T-
cells are a major infiltrating cell type, and our data is consistent with this suggestion.
CXCL10 has been implicated in T-cell migration into the brain in WNV and SFV infections
[63, 66] and S1P is an important regulator of T-cell migration from lymph nodes in the periph-
ery [67]. CXCL10 was induced following DENV-brain infection of WT mice in our study but
S1P was unchanged, supporting a potential role of CXCL10 but not S1P in driving CD8+ T-
cell infiltration during DENV-infection of the brain. The induction of CXCL10 mRNA at 3
dpi and prior to the onset of T-cell infiltration at 6 dpi further supports this association. Addi-
tionally, in our study a lack of SK1 did not affect DENV-induced responses of CXCL10 or S1P
and consistent with this, a lack of SK1 did not affect T-cell infiltration in the brain during
DENV infection.
In summary, in this study we have shown that SK1 has a moderate effect on body weight
loss and DENV RNA levels following DENV-2 infection in the mouse brain but has no overall
major impact on DENV-induced disease. While DENV-infection induced ISGs and CD8+T-
cell infiltration, the SK/S1P axis is not affected by DENV-infection and none of these factors
were significantly affected by the absence of SK1. This data has defined innate responses to
DENV-infection in the brain and demonstrate that in contrast to our studies showing a role of
SK1 in promoting ISG induction following DENV-infection in vitro, and other studies demon-
strating a role for SK1 in non-infectious neuroinflammation, in the scenario of DENV-infec-
tion of the brain, SK1 does not play a role in these processes.
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